vs
Side-by-side financial comparison of GAIA, INC (GAIA) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.
GAIA, INC is the larger business by last-quarter revenue ($25.5M vs $13.3M, roughly 1.9× OCULAR THERAPEUTIX, INC). GAIA, INC runs the higher net margin — -0.3% vs -488.0%, a 487.7% gap on every dollar of revenue. On growth, GAIA, INC posted the faster year-over-year revenue change (5.8% vs -22.4%). GAIA, INC produced more free cash flow last quarter ($76.0K vs $-57.1M). Over the past eight quarters, GAIA, INC's revenue compounded faster (9.4% CAGR vs -5.3%).
Gaia, Inc. is a publicly traded (NASDAQ:GAIA) American media company founded in 1988 by Jirka Rysavy in Louisville, Colorado. It owns and operates Gaia TV, a subscription video on-demand service consisting of original and licensed alternative media documentaries, including those on wellness, spirituality and conspiracy theories.
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
GAIA vs OCUL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $13.3M |
| Net Profit | $-75.0K | $-64.7M |
| Gross Margin | 87.6% | 88.0% |
| Operating Margin | -2.6% | -526.5% |
| Net Margin | -0.3% | -488.0% |
| Revenue YoY | 5.8% | -22.4% |
| Net Profit YoY | 91.7% | -33.6% |
| EPS (diluted) | $-0.02 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $13.3M | ||
| Q3 25 | $25.0M | $14.5M | ||
| Q2 25 | $24.6M | $13.5M | ||
| Q1 25 | $23.8M | $10.7M | ||
| Q4 24 | $24.1M | $17.1M | ||
| Q3 24 | $22.0M | $15.4M | ||
| Q2 24 | $21.9M | $16.4M | ||
| Q1 24 | $21.3M | $14.8M |
| Q4 25 | $-75.0K | $-64.7M | ||
| Q3 25 | $-1.2M | $-69.4M | ||
| Q2 25 | $-2.0M | $-67.8M | ||
| Q1 25 | $-1.2M | $-64.1M | ||
| Q4 24 | $-907.0K | $-48.4M | ||
| Q3 24 | $-1.2M | $-36.5M | ||
| Q2 24 | $-2.2M | $-43.8M | ||
| Q1 24 | $-971.0K | $-64.8M |
| Q4 25 | 87.6% | 88.0% | ||
| Q3 25 | 86.4% | 87.8% | ||
| Q2 25 | 86.7% | 85.6% | ||
| Q1 25 | 87.7% | 88.2% | ||
| Q4 24 | 88.2% | 92.8% | ||
| Q3 24 | 86.1% | 89.9% | ||
| Q2 24 | 84.5% | 90.8% | ||
| Q1 24 | 85.3% | 91.0% |
| Q4 25 | -2.6% | -526.5% | ||
| Q3 25 | -5.0% | -472.3% | ||
| Q2 25 | -8.9% | -502.6% | ||
| Q1 25 | -4.3% | -597.5% | ||
| Q4 24 | -7.1% | -296.1% | ||
| Q3 24 | -5.3% | -298.2% | ||
| Q2 24 | -9.1% | -265.1% | ||
| Q1 24 | -4.0% | -214.0% |
| Q4 25 | -0.3% | -488.0% | ||
| Q3 25 | -4.6% | -477.3% | ||
| Q2 25 | -8.3% | -503.9% | ||
| Q1 25 | -5.1% | -598.7% | ||
| Q4 24 | -3.8% | -283.3% | ||
| Q3 24 | -5.4% | -236.6% | ||
| Q2 24 | -9.9% | -266.3% | ||
| Q1 24 | -4.6% | -438.9% |
| Q4 25 | $-0.02 | $-0.27 | ||
| Q3 25 | $-0.05 | $-0.38 | ||
| Q2 25 | $-0.07 | $-0.39 | ||
| Q1 25 | $-0.04 | $-0.38 | ||
| Q4 24 | $-0.03 | $-0.25 | ||
| Q3 24 | $-0.05 | $-0.22 | ||
| Q2 24 | $-0.09 | $-0.26 | ||
| Q1 24 | $-0.05 | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.5M | $737.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $87.9M | $654.3M |
| Total Assets | $154.6M | $808.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.5M | $737.1M | ||
| Q3 25 | $14.2M | $344.8M | ||
| Q2 25 | $13.9M | $391.1M | ||
| Q1 25 | $13.1M | $349.7M | ||
| Q4 24 | $5.9M | $392.1M | ||
| Q3 24 | $4.4M | $427.2M | ||
| Q2 24 | $5.5M | $459.7M | ||
| Q1 24 | $8.6M | $482.9M |
| Q4 25 | $87.9M | $654.3M | ||
| Q3 25 | $86.3M | $258.2M | ||
| Q2 25 | $85.7M | $305.9M | ||
| Q1 25 | $87.0M | $265.9M | ||
| Q4 24 | $80.7M | $315.3M | ||
| Q3 24 | $81.2M | $352.0M | ||
| Q2 24 | $82.1M | $377.7M | ||
| Q1 24 | $84.8M | $408.0M |
| Q4 25 | $154.6M | $808.1M | ||
| Q3 25 | $151.1M | $410.9M | ||
| Q2 25 | $147.0M | $451.3M | ||
| Q1 25 | $148.5M | $405.9M | ||
| Q4 24 | $141.2M | $457.9M | ||
| Q3 24 | $139.6M | $490.4M | ||
| Q2 24 | $142.1M | $517.1M | ||
| Q1 24 | $133.8M | $538.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-54.2M |
| Free Cash FlowOCF − Capex | $76.0K | $-57.1M |
| FCF MarginFCF / Revenue | 0.3% | -430.9% |
| Capex IntensityCapex / Revenue | 6.6% | 21.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.0K | $-216.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8M | $-54.2M | ||
| Q3 25 | $326.0K | $-50.7M | ||
| Q2 25 | $2.3M | $-55.2M | ||
| Q1 25 | $1.3M | $-44.7M | ||
| Q4 24 | $2.7M | $-39.4M | ||
| Q3 24 | $409.0K | $-36.6M | ||
| Q2 24 | $-2.1M | $-24.8M | ||
| Q1 24 | $5.9M | $-33.9M |
| Q4 25 | $76.0K | $-57.1M | ||
| Q3 25 | $-1.6M | $-56.7M | ||
| Q2 25 | $880.0K | $-56.5M | ||
| Q1 25 | $268.0K | $-46.6M | ||
| Q4 24 | $1.6M | $-39.6M | ||
| Q3 24 | $-952.0K | $-36.6M | ||
| Q2 24 | $-3.5M | $-25.5M | ||
| Q1 24 | $4.9M | $-34.1M |
| Q4 25 | 0.3% | -430.9% | ||
| Q3 25 | -6.4% | -390.0% | ||
| Q2 25 | 3.6% | -419.7% | ||
| Q1 25 | 1.1% | -435.6% | ||
| Q4 24 | 6.5% | -232.0% | ||
| Q3 24 | -4.3% | -237.6% | ||
| Q2 24 | -16.1% | -155.4% | ||
| Q1 24 | 22.8% | -231.1% |
| Q4 25 | 6.6% | 21.4% | ||
| Q3 25 | 7.7% | 41.2% | ||
| Q2 25 | 5.7% | 9.3% | ||
| Q1 25 | 4.3% | 18.1% | ||
| Q4 24 | 4.6% | 1.2% | ||
| Q3 24 | 6.2% | 0.6% | ||
| Q2 24 | 6.6% | 4.5% | ||
| Q1 24 | 5.0% | 1.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GAIA
| US | $16.7M | 65% |
| Non Us | $8.8M | 35% |
OCUL
Segment breakdown not available.
